Fulminant Respiratory Failure Caused by Anti-asparaginyl tRNA Synthetase (Anti-KS) Antibody Syndrome-related Interstitial Lung Disease

Figures

• 

  Figure 1.. Chest X-ray findings on the 2nd (A), 8th (B), and 39th (C) day of hospitalization.

• 

  Figure 2.. Computed tomography (CT) shows diffuse ground-glass opacities (GGOs) and consolidation in both lungs on the second day of hospitalization (A-C). CT shows that the GGOs in both upper lobes and consolidation in both lower lobes were reduced on the eighth day of hospitalization (D-F). Chest CT shows residual reticular shadows in both lower lobes on the 39th day of hospitalization (G-I).

• 

  Figure 3.. Computed tomography (CT) shows that the reticular shadows in the left lower lobes worsened from 18 weeks (A) to 48 weeks (B) after the onset. CT shows consolidation in the left lower lobes 72 weeks after the onset (C). CT shows that consolidation in the left lower lobes was reduced at 86 weeks after the onset (D).

• 

  Figure 4.. Clinical course. KL-6: Krebs von den Lungen-6, SP-D: surfactant protein-D, PSL: prednisolone, CyA: cyclosporine